Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea |
Cho, Hye Hyun
(Department of Biomedical Laboratory Science, Jeonju Kijeon College)
Kwon, Gye Cheol (Department of Laboratory Medicine, College of Medicine, Chungnam National University) Kim, Semi (Department of Laboratory Medicine, College of Medicine, Chungnam National University) Koo, Sun Hoe (Department of Laboratory Medicine, College of Medicine, Chungnam National University) |
1 | Yong D, Shin HB, Kim YK, Cho J, Lee WG, Ha GY, et al. 2014. Increase in the prevalence of carbapenem-resistant Acinetobacter isolates and ampicillin-resistant non-typhoidal Salmonella species in Korea: a KONSAR study conducted in 2011. Infect. Chemother. 46: 84-93. DOI |
2 | Sevillano E, Gallego L, García-Lobo JM. 2009. First detection of the OXA-40 carbapenemase in P. aeruginosa isolates, located on a plasmid also found in A. baumannii. Pathol. Biol. (Paris) 57: 493-495. DOI |
3 | Tian GB, Adams-Haduch JM, Bogdanovich T, Wang HN, Doi Y. 2011. PME-1, an extended-spectrum β-lactamase identified in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 55: 2710-2713. DOI |
4 | Upadhyay S, Mishra S, Sen MR, Banerjee T, Bhattacharjee A. 2013. Co-existence of Pseudomonas-derived cephalosporinase among plasmid encoded CMY-2 harbouring isolates of Pseudomonas aeruginosa in north India. Indian J. Med. Microbiol. 31: 257-260. DOI |
5 | Viedma E, Juan C, Acosta J, Zamorano L, Otero JR, Sanz F, et al. 2009. Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum β-lactamases GES-1 and GES-5 in Spain. Antimicrob. Agents Chemother. 53: 4930-4933. DOI |
6 | Wang J, Zhou JY, Qu TT, Shen P, Wei ZQ, Yu YS, et al. 2010. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals. Int. J. Antimicrob. Agents 35: 486-491. DOI |
7 | Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, et al. 2006. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents 27: 351-353. DOI |
8 | Wright LL, Turton JF, Livermore DM, Hopkins KL, Woodford N. 2015. Dominance of international ‘high-risk clones’ among metallo-β-lactamase-producing Pseudomonas aeruginosa in the UK. J. Antimicrob. Chemother. 70: 103-110. DOI |
9 | Pollini S, Maradei S, Pecile P, Olivo G, Luzzaro F, Docquier JD, et al. 2013. FIM-1, a new acquired metallo-β-lactamase from a Pseudomonas aeruginosa clinical isolate from Italy. Antimicrob. Agents Chemother. 57: 410-416. DOI |
10 | Poole K. 2011. Pseudomonas aeruginosa: resistance to the max. Front Microbiol. 2: 65. DOI |
11 | Qing Y, Cao KY, Fang ZL, Huang YM, Zhang XF, Tian GB, et al. 2014. Outbreak of PER-1 and diversity of β-lactamases among ceftazidime-resistant Pseudomonas aeruginosa clinical isolates. J. Med. Microbiol. 63: 386-392. DOI |
12 | Quale J, Bratu S, Gupta J, Landman D. 2006. Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates. Antimicrob. Agents Chemother. 50: 1633-1641. DOI |
13 | Raimondi A, Sisto F, Nikaido H. 2001. Mutation in Serratia marcescens AmpC β-lactamase producing high-level resistance to ceftazidime and cefpirome. Antimicrob. Agents Chemother. 45: 2331-2339. DOI |
14 | Rodríguez-Martínez JM, Poirel L, Nordmann P. 2009. Extended-spectrum cephalosporinases in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 53: 1766-1771. DOI |
15 | Rodríguez-Martínez JM, Poirel L, Nordmann P. 2009. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 53: 4783-4788. DOI |
16 | Pasteran F, Faccone D, Petroni A, Rapoport M, Galas M, Vázquez M, et al. 2005. Novel variant (bla(VIM-11)) of the metallo-{β}-lactamase bla(VIM) family in a GES-1 extendedspectrum-{β}-lactamase-producing Pseudomonas aeruginosa clinical isolate in Argentina. Antimicrob. Agents Chemother. 49: 474-475. DOI |
17 | Sanbongi Y, Shimizu A, Suzuki T, Nagaso H, Ida T, Maebashi K, et al. 2009. Classification of OprD sequence and correlation with antimicrobial activity of carbapenem agents in Pseudomonas aeruginosa clinical isolates collected in Japan. Microbiol. Immunol. 53: 361-367. DOI |
18 | Neyestanaki DK, Mirsalehian A, Rezagholizadeh F, Jabalameli F, Taherikalani M, Emaneini M. 2014. Determination of extended spectrum β-lactamases, metallo-β-lactamases and AmpC-β-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients. Burns 40: 1556-1561. DOI |
19 | Pasteran F, Faccone D, Gomez S, De Bunder S, Spinelli F, Rapoport M, et al. 2012. Detection of an international multiresistant clone belonging to sequence type 654 involved in the dissemination of KPC-producing Pseudomonas aeruginosa in Argentina. J. Antimicrob. Chemother. 67: 1291-1293. DOI |
20 | Pellegrino FL, Teixeira LM, Carvalho Md Mda G, Aranha Nouér S, Pinto De Oliveira M, Mello Sampaio JL, et al. 2002. Occurrence of a multidrug-resistant Pseudomonas aeruginosa clone in different hospitals in Rio de Janeiro, Brazil. J. Clin. Microbiol. 40: 2420-2424. DOI |
21 | Pérez-Pérez FJ, Hanson ND. 2002. Detection of plasmidmediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 40: 2153-2162. DOI |
22 | Philippon A, Arlet G, Jacoby GA. 2002. Plasmid-determined AmpC-type beta-lactamases. Antimicrob. Agents Chemother. 46: 1-11. DOI |
23 | Cornaglia G, Giamarellou H, Rossolini GM. 2011. Metallo-β-lactamases: a last frontier for β-lactams? Lancet Infect. Dis. 11: 381-393. DOI |
24 | Poirel L, Walsh TR, Cuvillier V, Nordmann P. 2011. Multiplex PCR for detection of acquired carbapenemase genes. Diagn. Microbiol. Infect. Dis. 70: 119-123. DOI |
25 | Cho HH, Kwon KC, Sung JY, Koo SH. 2013. Prevalence and genetic analysis of multidrug-resistant Pseudomonas aeruginosa ST235 isolated from a hospital in Korea, 2008-2012. Ann. Clin. Lab. Sci. 43: 414-419. |
26 | Clinical and Laboratory Standards Institute. 2012. Performance standards for antimicrobial susceptibility testing: twentysecond informational supplement. M100-S22. CLSI, Wayne, Pennsylavania. |
27 | Grover N, Sahni AK, Bhattacharya S. 2013. Therapeutic challenges of ESBLS and AmpC β-lactamase producers in a tertiary care center. Med. J. Armed Forces India 69: 4-10. DOI |
28 | Huang YT, Chang SC, Lauderdale TL, Yang AJ, Wang JT. 2007. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa carrying metallo-beta-lactamase genes in Taiwan. Diagn. Microbiol. Infect. Dis. 59: 211-216. DOI |
29 | Hu LF, Chang X, Ye Y, Wang ZX, Shao YB, Shi W, et al. 2011. Stenotrophomonas maltophilia resistance to trimethoprim/ sulfamethoxazole mediated by acquisition of sul and dfrA genes in a plasmid-mediated class 1 integron. Int. J. Antimicrob. Agents 37: 230-234. DOI |
30 | Jacoby GA. 2009. AmpC β-lactamases. Clin. Microbiol. Rev. 22: 161-182. DOI |
31 | Lister PD, Wolter DJ, Hanson ND. 2009. Antibacterialresistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin. Microbiol. Rev. 22: 582-610. DOI |
32 | Bae IK, Suh B, Jeong SH, Wang KK, Kim YR, Yong D, et al. 2014. Molecular epidemiology of Pseudomonas aeruginosa clinical isolates from Korea producing β-lactamases with extended-spectrum activity. Diagn. Microbiol. Infect. Dis. 79: 373-377. DOI |
33 | Mammeri H, Nordmann P. 2007. Extended-spectrum cephalosporinases in Enterobacteriaceae. Anti-Infect. Agents Med. 6: 71-82. DOI |